A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020

Clinical trial NCT00165659 · COMPLETED

Trial details

NCT number: NCT00165659
Sponsor: Eisai Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2002-11-01
Primary completion: 2005-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.